{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:45:39Z","timestamp":1790484339799,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s13318-016-0319-4","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T09:25:46Z","timestamp":1453973146000},"page":"59-68","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Ocular Drug Distribution After Topical Administration: Population Pharmacokinetic Model in Rabbits"],"prefix":"10.1007","volume":"42","author":[{"given":"Nassim","family":"Djebli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Khier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Griguer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Coutant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Tavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Leriche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,28]]},"reference":[{"issue":"7","key":"319_CR1","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1002\/jps.21200","volume":"97","author":"Y Shirasaki","year":"2008","unstructured":"Shirasaki Y. Molecular design for enhancement of ocular penetration. J Pharm Sci. 2008;97(7):2462\u201396.","journal-title":"J Pharm Sci"},{"issue":"5","key":"319_CR2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1081\/DDC-120003445","volume":"28","author":"IP Kaur","year":"2002","unstructured":"Kaur IP, Kanwar M. Ocular preparations: the formulation approach. Drug Dev Ind Pharm. 2002;28(5):473\u201393.","journal-title":"Drug Dev Ind Pharm"},{"key":"319_CR3","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/j.clinthera.2008.10.020","volume":"30","author":"G Torkildsen","year":"2008","unstructured":"Torkildsen G, O\u2019Brien TP. Conjunctival tissue pharmacokinetic properties of topical azithromycin 1\u00a0% and moxifloxacin 0.5\u00a0% ophthalmic solutions: a single-dose, randomized, open-label, active-controlled trial in healthy adult volunteers. Clin Ther. 2008;30:2005\u201314.","journal-title":"Clin Ther"},{"key":"319_CR4","first-page":"1621","volume":"40","author":"K Schmitz","year":"1999","unstructured":"Schmitz K, Banditt P, Motschmann M, et al. Population pharmacokinetics of 2\u00a0% topical dorzolamide in the aqueous humor of humans. Invest Ophthalmol Vis Sci. 1999;40:1621\u20134.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"319_CR5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.exer.2015.05.003","volume":"137","author":"EM Amo Del","year":"2015","unstructured":"Del Amo EM, Urtti A. Rabbit as an animal model for intravitreal pharmacokinetics: clinical predictability and quality of the published data. Exp Eye Res. 2015;137:111\u201324.","journal-title":"Exp Eye Res"},{"issue":"12","key":"319_CR6","doi-asserted-by":"crossref","first-page":"5995","DOI":"10.1128\/JVI.00034-11","volume":"85","author":"S Sharma","year":"2011","unstructured":"Sharma S, Mulik S, Kumar N, et al. An anti-inflammatory role of VEGFR2\/Src kinase inhibitor in HSV-1 induced immunopathology. J Virol. 2011;85(12):5995\u20136007.","journal-title":"J Virol"},{"key":"319_CR7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0939-6411(97)00064-7","volume":"44","author":"N Worakul","year":"1997","unstructured":"Worakul N, Robinson JR. Ocular pharmacokinetics\/pharmacodynamics. Eur J Pharm Biopharm. 1997;44:71\u201383.","journal-title":"Eur J Pharm Biopharm"},{"key":"319_CR8","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.addr.2006.07.025","volume":"58","author":"VP Ranta","year":"2006","unstructured":"Ranta VP, Urtti A. Transscleral drug delivery to the posterior eye: prospects of pharmacokinetic modeling. Adv Drug Deliv Rev. 2006;58:1164\u201381.","journal-title":"Adv Drug Deliv Rev"},{"key":"319_CR9","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","volume":"57","author":"PM Hughes","year":"2005","unstructured":"Hughes PM, Olejnik O, Chang-Lin JE, et al. Topical and systemic drug delivery to the posterior segments. Adv Drug Deliv Rev. 2005;57:2010\u201332.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"319_CR10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/sj.clpt.6100241","volume":"82","author":"MO Karlsson","year":"2007","unstructured":"Karlsson MO, Savic RM. Diagnosing model diagnostics. Clin Pharmacol Ther. 2007;82(1):17\u201320.","journal-title":"Clin Pharmacol Ther"},{"issue":"2","key":"319_CR11","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1208\/s12248-011-9255-z","volume":"13","author":"M Bergstrand","year":"2011","unstructured":"Bergstrand M, Hooker AC, Wallin JE, et al. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13(2):143\u201351.","journal-title":"AAPS J"},{"issue":"1","key":"319_CR12","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/jps.22764","volume":"101","author":"CR Pamulapati","year":"2012","unstructured":"Pamulapati CR, Schoenwald RD. Ocular pharmacokinetics of a novel tetrahydroquinoline analog in rabbit: compartmental analysis and PK-PD evaluation. J Pharm Sci. 2012;101(1):414\u201323.","journal-title":"J Pharm Sci"},{"issue":"5","key":"319_CR13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1023\/B:PHAM.0000026426.20012.36","volume":"21","author":"K Sakanaka","year":"2004","unstructured":"Sakanaka K, Kawazu K, Tomonari M, et al. Ocular pharmacokinetic\/pharmacodynamic modeling for bunazosin after instillation into rabbits. Pharm Res. 2004;21(5):770\u20136.","journal-title":"Pharm Res"},{"issue":"8","key":"319_CR14","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1248\/bpb.31.1590","volume":"31","author":"K Sakanaka","year":"2008","unstructured":"Sakanaka K, Kawazu K, Tomonari M, et al. Ocular pharmacokinetic\/pharmacodynamic modeling for multiple anti-glaucoma drugs. Biol Pharm Bull. 2008;31(8):1590\u20135.","journal-title":"Biol Pharm Bull"},{"issue":"5","key":"319_CR15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00228-007-0457-3","volume":"64","author":"K Abduljalil","year":"2008","unstructured":"Abduljalil K, Diestelhorst M, Doroshyenko O, et al. Modelling ocular pharmacokinetics of fluorescein administered as lyophilisate or conventional eye drops. Eur J Clin Pharmacol. 2008;64(5):521\u20139.","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"319_CR16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1208\/s12248-010-9183-3","volume":"12","author":"R Gaudana","year":"2010","unstructured":"Gaudana R, Ananthula HK, Parenky A, et al. Ocular drug delivery. AAPS J. 2010;12(3):348\u201360.","journal-title":"AAPS J"},{"issue":"3","key":"319_CR17","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4155\/tde.10.40","volume":"1","author":"UB Kompella","year":"2010","unstructured":"Kompella UB, Kadam RS, Lee VH. Recent advances in ophthalmic drug delivery. Ther Deliv. 2010;1(3):435\u201356.","journal-title":"Ther Deliv"}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0319-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13318-016-0319-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0319-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-016-0319-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:07:59Z","timestamp":1553627279000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13318-016-0319-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,28]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["319"],"URL":"https:\/\/doi.org\/10.1007\/s13318-016-0319-4","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"value":"0378-7966","type":"print"},{"value":"2107-0180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,28]]}}}